The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's priorities might be on hot button issues ...
SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its ...
N ORTHVILLE — Malik Beasley couldn’t share with his mother, Deena, that the Detroit Pistons were one of three teams he was ...
Pharma Digs in on Changes It Wants From Trump Administration By Deena Beasley SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices ...